Simvastatin mechanism of action

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Simvastatin Mechanism of Action: HMG-CoA Reductase Inhibition and Cholesterol Synthesis

Simvastatin is primarily known as an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the key enzyme in the cholesterol biosynthesis pathway. By blocking this enzyme, simvastatin reduces the production of cholesterol in the liver, which is its main mechanism for lowering blood cholesterol levels and treating cardiovascular diseases 2469.

Pleiotropic Effects: Beyond Cholesterol Lowering

Cardiovascular Protection and Vasorelaxation

Simvastatin has several effects beyond cholesterol reduction. It promotes vasorelaxation by activating the nitric oxide (NO)/cyclic guanosine monophosphate (cGMP) pathway, modulating angiotensin II type 2 receptors, and affecting calcium and potassium channels in blood vessels. These actions help relax blood vessels and improve blood flow . Simvastatin also activates the protein kinase Akt, which enhances endothelial nitric oxide synthase (eNOS) activity, leading to increased NO production and further vascular protection . Additionally, simvastatin induces heme oxygenase-1 (HO-1) in vascular smooth muscle cells, contributing to anti-inflammatory and antiproliferative effects in blood vessels .

Antithrombotic Activity

Simvastatin reduces blood clotting by inhibiting the activation of key coagulation factors such as prothrombin, factor V, and factor XIII, and by enhancing the inactivation of factor Va. These effects are independent of its cholesterol-lowering action and help decrease the risk of thrombosis .

Anti-Fibrotic and Anti-Inflammatory Effects

Simvastatin can attenuate cardiac fibrosis by regulating exosome-mediated communication between heart cells. It reduces collagen deposition and the transformation of fibroblasts to myofibroblasts, which are key processes in the development of fibrosis . The drug also exerts anti-inflammatory effects by inhibiting nuclear factor-kappa B (NF-κB) activation and reducing nitric oxide production in vascular smooth muscle cells, largely through the induction of HO-1 .

Cellular and Metabolic Effects

Glucose Uptake and Insulin Sensitivity

Simvastatin can suppress glucose uptake and GLUT4 translocation in muscle cells by inhibiting the insulin receptor (IR)/IRS-1/Akt signaling pathway. This effect may contribute to the increased risk of new-onset diabetes observed with long-term statin therapy .

Cell Cycle Regulation and Anticancer Activity

In cancer cells, simvastatin induces cell cycle arrest at the G0/G1 phase by upregulating the cell cycle inhibitors p21 and p27. This is achieved through activation of AMP-activated protein kinase (AMPK) and inhibition of the STAT3/SKP2 axis, which together prevent cell proliferation and tumor growth . Simvastatin also activates AMPK in other cell types, linking cholesterol metabolism to cellular energy status and autophagy .

Effects on Bone and Stem Cells

Simvastatin promotes osteoblastic (bone-forming) differentiation and inhibits adipocytic (fat-forming) differentiation in bone marrow stromal cells, partly by increasing bone morphogenetic protein 2 (BMP2) expression .

Cholesterol-Independent (Pleiotropic) Mechanisms

Some beneficial effects of simvastatin, such as reducing brain atrophy and slowing disability progression in multiple sclerosis, occur independently of cholesterol lowering. These effects may involve upstream metabolites of the cholesterol synthesis pathway and other cellular signaling mechanisms .

Conclusion

Simvastatin acts mainly by inhibiting HMG-CoA reductase to lower cholesterol, but it also has many cholesterol-independent effects. These include improving blood vessel function, reducing blood clotting, preventing fibrosis and inflammation, affecting glucose metabolism, regulating cell growth, and promoting bone formation. These diverse actions make simvastatin a valuable drug for cardiovascular and other health conditions 12345678+2 MORE.

Sources and full results

Most relevant research papers on this topic

Simvastatin Attenuates Cardiac Fibrosis via Regulation of Cardiomyocyte-Derived Exosome Secretion

Simvastatin reduces cardiac fibrosis by regulating exosome-mediated communication within cardiomyocytes, offering potential as a novel therapy for cardiac fibrosis.

Non-RCTAnimal StudyRigorous Journal

2019·

47citations

·Hsuan-Fu Kuo et al.

Simvastatin inhibits glucose uptake activity and GLUT4 translocation through suppression of the IR/IRS-1/Akt signaling in C2C12 myotubes.

Simvastatin inhibits glucose uptake and GLUT4 translocation in C2C12 myotubes through suppression of the insulin receptor/IRS-1/Akt pathway, potentially increasing the risk of new-onset diabetes.

In Vitro StudyRigorous Journal

2016·

43citations

·Weihua Li et al.

New insights on mode of action of vasorelaxant activity of simvastatin

Simvastatin's vasorelaxant effect involves NO/cGMP pathways, AT2R receptors, calcium channels, and K+ channels, with some inhibition by cGMP inhibitors.

In Vitro Study

2023·

5citations

·Kanika Verma et al.

Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells

Simvastatin induces G0/G1 arrest in hepatocellular carcinoma cells by upregulating p21 and p27, promoting cell death, and reducing tumor growth in vitro and in vivo.

In Vitro StudyHighly Cited

2017·

126citations

·Sin-Ting Wang et al.

Simvastatin Depresses Blood Clotting by Inhibiting Activation of Prothrombin, Factor V, and Factor XIII and by Enhancing Factor Va Inactivation

Simvastatin treatment reduces blood clotting by inhibiting prothrombin activation, factor Va generation, fibrinogen cleavage, factor XIII activation, and increasing factor Va inactivation, unrelated to cholesterol reduction.

Non-RCTHighly Cited

2001·

256citations

·A. Undas et al.

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.

Simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals, potentially explaining their beneficial side effects, including new blood vessel growth.

Non-RCTAnimal StudyHighly Cited

2000·

1491citations

·Y. Kureishi et al.

Simvastatin Induces Heme Oxygenase-1: A Novel Mechanism of Vessel Protection

Simvastatin activates heme oxygenase-1 in vascular smooth muscle cells, largely contributing to its antiinflammatory and antiproliferative effects.

In Vitro StudyHighly Cited

2004·

285citations

·Tzong-Shyuan Lee et al.

Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis

Simvastatin's beneficial effects in progressive multiple sclerosis are independent of lowering serum cholesterol levels, suggesting a role for upstream intermediate metabolites of the cholesterol synthesis pathway.

2019·

30citations

·A. Eshaghi et al.

The anti-tubercular activity of simvastatin is mediated by cholesterol-driven autophagy via the AMPK-mTORC1-TFEB axis.

Simvastatin's anti-tubercular activity involves inhibiting cholesterol biosynthesis and promoting autophagy, revealing new links between cholesterol homeostasis and Mycobacterium tuberculosis infection control.

In Vitro Study

2020·

6citations

·N. Bruiners et al.

Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells.

Simvastatin enhances osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells, partially through inducing BMP 2 expression.

In Vitro StudyHighly Cited

2003·

191citations

·Chunli Song et al.

Try another search

fever temperature ranges

solar physics research

management of hypotension

stellar formation and evolution

natural disasters and their impact

type 2 diabetes treatment options